GERN

Geron Corporation

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$1.66

Market Cap

$1.06B

Beta

0.67

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+138.83%

EPS Growth (YoY)+52.42%

Revenue CAGR 3Y+500.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-10.45%

Debt / Equity1.11

Interest Coverage-1.6x

No credit card required

Already have an account? Sign in to view the full analysis for GERN.